 NEW YORK, Aug. 9, 2021 PRNewswire -- Oramed Pharmaceuticals Inc. Nasdaq: ORMP TASE: ORMP a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Chief Commercial Officer Michael Rabinowitz will present a company overview at Canaccord Genuitys 41st Annual Growth Conference, held virtually this year from August 10-12, 2021. Mr. 